GlassScriptPhysician profile
Joyce A Bell
NPI 1497217277
$4,061.90
in general payments reported to CMS, 2019-2025
30 companies · $1,239 in 2025
The $1,239 reported for 2025 was more than what 90% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,883 · 2022: $288 · 2023: $150 · 2024: $502 · 2025: $1,239.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,427 · Travel and Lodging: $339 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $125.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,426.82 |
| Travel and Lodging | $339.29 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $125.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,105.96 | 2021-2025 | |
| Boston Scientific Corporation | $615.09 | 2024-2025 | Rezum Generator |
| Sumitomo Pharma America, INC. | $361.59 | 2023-2025 | Gemtesa |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $250.86 | 2021-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $248.17 | 2021-2022 | |
| Nestle Healthcare Nutrition INC. | $161.74 | 2021-2022 | |
| Teleflex LLC | $142.96 | 2024-2025 | Urolift, Barrigel |
| Janssen Biotech, INC. | $140.38 | 2021-2023 | Erleada |
| Janssen Scientific Affairs, LLC | $124.99 | 2021 | |
| Medtronic, INC. | $120.03 | 2024-2025 | Interstim |
| Astellas Pharma US INC | $109.79 | 2024 | Cresemba |
| Endo Pharmaceuticals INC. | $78.92 | 2023-2024 | Xiaflex, Aveed |
| Urogen Pharma, INC. | $76.73 | 2025 | |
| Coloplast Corp | $62.84 | 2025 | |
| Calyxo, INC. | $45.27 | 2025 | Cvac Aspiration System |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ironwood Pharmaceuticals, INC | $43.94 | 2021 | |
| Intercept Pharmaceuticals, INC. | $42.65 | 2021-2022 | |
| Pfizer INC. | $42.44 | 2021 | |
| Endo USA, INC. | $42.01 | 2024-2025 | Xiaflex, Aveed |
| Abc Home Medical Supply, INC. | $39.18 | 2025 | |
| Genzyme Corporation | $27.56 | 2023 | |
| 180 Medical, INC. | $26.52 | 2025 | |
| Daiichi Sankyo INC. | $23.78 | 2021 | |
| Novartis Pharmaceuticals Corporation | $23.42 | 2025 | |
| C. R. Bard, INC. & Subsidiaries | $21.96 | 2025 | Personal Catheter Intermittent Catheter |
| Merck Sharp & Dohme LLC | $18.00 | 2021 | |
| Immunitybio, INC. | $17.65 | 2025 | |
| Braintree Laboratories, INC. | $17.21 | 2021 | |
| Photocure INC | $15.82 | 2024 | Cysview |
| Ethicon US, LLC | $14.44 | 2025 | Echelon; Endopath |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joyce Bell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.